Nosisa Sipambo to Anti-HIV Agents
This is a "connection" page, showing publications Nosisa Sipambo has written about Anti-HIV Agents.
Connection Strength
0,523
-
Ongoing High Prevalence of Severe Immune Suppression Among Children in South Africa. J Acquir Immune Defic Syndr. 2023 04 01; 92(4):273-280.
Score: 0,115
-
Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts. Antivir Ther. 2023 02; 28(2):13596535231168480.
Score: 0,114
-
Virologic response of adolescents living with perinatally acquired HIV receiving antiretroviral therapy in the period of early adolescence (10-14 years) in South Africa. AIDS. 2021 05 01; 35(6):971-978.
Score: 0,101
-
Recording of HIV viral loads and viral suppression in South African patients receiving antiretroviral treatment: a multicentre cohort study. Antivir Ther. 2020; 25(5):257-266.
Score: 0,092
-
Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa. Glob Health Action. 2013 Jan 24; 6:19248.
Score: 0,057
-
Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern Africa. J Int AIDS Soc. 2020 07; 23(7):e25546.
Score: 0,024
-
Lamivudine monotherapy in children and adolescents: The devil is in the detail. S Afr Med J. 2017 Nov 27; 107(12):1055-1057.
Score: 0,020